National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Cilazapril Anhydrous
Synonyms

Cilazapril Anhydrous

CILAZAPRIL ANHYDROUS

Definitions

The anhydrous form of the pyridazine angiotensin-converting enzyme (ACE) inhibitor cilazapril with antihypertensive activity. As a prodrug cilazapril is rapidly metabolized in the liver to cilazaprilat; cilazaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Cilazaprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C76134

CAS_Registry

88768-40-5

Chemical_Formula

C22H31N3O5

code

C76134

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

The anhydrous form of the pyridazine angiotensin-converting enzyme (ACE) inhibitor cilazapril with antihypertensive activity. As a prodrug cilazapril is rapidly metabolized in the liver to cilazaprilat; cilazaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Cilazaprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

FDA_UNII_Code

8Q9454114Q

FULL_SYN

Cilazapril Anhydrous

CILAZAPRIL ANHYDROUS

label

Cilazapril Anhydrous

Legacy Concept Name

Cilazapril_Anhydrous

Preferred_Name

Cilazapril Anhydrous

prefixIRI

Thesaurus:C76134

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0886706

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C247

Delete Subject Author Type Created
No notes to display